TRV GP V, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001990717

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024

Q2 2026 · 3 positions · Total reported value $498.24M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 33.3% · 0 new · 1 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, TRV GP V, LLC disclosed 3 equity positions with a combined reported value of $498.24M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were RAPP ($261.71M), SEPN ($208.16M), MAZE ($28.37M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, TRV GP V, LLC opened 0 new positions, trimmed 1 and fully exited 0, a turnover rate of 33.3% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest TRV GP V, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

TRV GP V is an SEC-registered 13F filer. As of Q2 2026 it reported 3 US equity positions with a combined value of $498.24M. HoldingsHub carries 7 quarters of its filings (Q4 2024–Q2 2026).

Portfolio Structure

  • 3 positions · $498.24M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: RAPP (RAPPORT THERAPEUTICS INC) at 52.5%
  • Average position size: $166.08M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 reduced
  • 2 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The TRV GP V, LLC fund appears to be maintaining a conservative stance with a focus on health care, indicating a potential preference for stability and growth within this sector. The reduction in the RAPP position suggests a slight cautiousness or a shift in emphasis within the health care sector. 2. Key Moves: - Reduce: RAPP (RAPPORT THERAPEUTICS INC) by 12.0% in terms of share count. - Hold: SEPN (SEPTERNA INC) and MAZE (MAZE THERAPEUTICS INCORPORATED) positions were maintained steady. - No New Positions: No new holdings were added. 3. Portfolio Structure: - Passive/Active: The fund seems to lean towards a passive management style as it maintains its positions rather than actively adding or removing them. - Sector Bias: The fund is heavily biased towards the health care sector, reflecting a focus on pharmaceuticals and biotechnology. - Risk Appetite: The risk appetite appears moderate, as there are no aggressive additions or deletions, and the focus is on maintaining positions rather than taking significant risks. 4. Per-Holding One-Liner: - RAPP: Focuses on developing novel therapies for various diseases. - SEPN: Engaged in the research and development of gene therapy products. - MAZE: Specializes in the development of treatments for neurological disorders. 5. One-Sentence Style Summary: TRV GP V, LLC maintained a conservative health care focus in Q2 2026, with a reduction in RAPP indicating a cautious approach to sector shifts, while SEPN and MAZE positions were held steady.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 6.28M $261.71M 52.53%
52.53%
Reduce
2 6.22M $208.16M 41.78%
41.78%
Hold
3 950.80K $28.37M 5.69%
5.69%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 100% R 100% F1 100% (modelled on 2026-Q1; 3/10 hit)

Historical Backtest (5 quarters)

Avg precision 95% · recall 100% · F1 97% · avg rank error 0.3 · Top-10 turnover 4%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2025-Q2 100% 100% 100% RAPP · SEPN · MAZE · CRGX RAPP · SEPN · MAZE · CRGX
2025-Q3 75% 100% 86% RAPP · SEPN · MAZE · CRGX RAPP · SEPN · MAZE
2025-Q4 100% 100% 100% RAPP · SEPN · MAZE RAPP · SEPN · MAZE
2026-Q1 100% 100% 100% RAPP · SEPN · MAZE RAPP · SEPN · MAZE
2026-Q2 ★ 100% 100% 100% RAPP · SEPN · MAZE RAPP · SEPN · MAZE

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did TRV GP V, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, TRV GP V, LLC reported 3 equity positions worth $498.24M in aggregate; its largest disclosed positions were RAPP ($261.71M), SEPN ($208.16M), MAZE ($28.37M).

How large is TRV GP V, LLC's portfolio?

TRV GP V, LLC reported $498.24M of long equity holdings across 3 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is TRV GP V, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/trv-gp-v/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →